The rationale for prostaglandin E1 (alpha-alprostadil) in the management of male impotence.
Porst
H
H
D000527:Alprostadil / Q000627:therapeutic use*; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D018783:Impotence, Vasculogenic / Q000188:drug therapy*; D008297:Male; D008981:Molsidomine / Q000031:analogs & derivatives / Q000627:therapeutic use; D013948:Moxisylyte / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use; D010411:Penile Induration / Q000188:drug therapy*; D010646:Phentolamine / Q000627:therapeutic use
C002385:linsidomine; D008981:Molsidomine; D010208:Papaverine; D000527:Alprostadil; D013948:Moxisylyte; D010646:Phentolamine